3-(5-(Difluoromethyl)-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid

Catalog No. :
ACYQSI061
CAS No. :
1018151-04-6
Molecular Formula :
C9H8F2N4O3
Molecular Weight :
258.18

IUPAC Name:3-(5-(difluoromethyl)-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid

3-(5-(Difluoromethyl)-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$220.00Login to see priceInquiryInquiry
100mg98%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(5-(Difluoromethyl)-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid
IUPAC Name3-(5-(difluoromethyl)-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid
MDL No.MFCD10001656
Molecular FormulaC9H8F2N4O3
Molecular Weight258.18
SMILESO=C(O)CCC1=NN(C(NC(C(F)F)=C2)=N1)C2=O
InChI KeyRYZPHVTUDAZDQB-UHFFFAOYSA-N
Synonym3-[5-(difluoromethyl)-7-oxo-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]propanoic acid;3-[5-(difluoromethyl)-7-oxo-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]propanoic acid;[1,2,4]Triazolo[1,5-a]pyrimidine-2-propanoic acid, 5-(difluoromethyl)-1,7-dihydro-7-oxo-
CAS No.1018151-04-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYQSI061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYQSI061 route product structure diagram
    ACYQSI0611018151-04-6
Inquiry

2. ACYQSI061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYQSI061 route product structure diagram
    ACYQSI0611018151-04-6
Inquiry

Comments (0)